logo
What travel vaccines do I need for my trip? Everything you need to know

What travel vaccines do I need for my trip? Everything you need to know

Times14-05-2025

Few of us think about vaccinations before travel, but it can be crucial for certain destinations where the risk of infectious diseases is high. But far from just keeping us healthy, vaccinations can also form part of a country's entry requirements, especially for diseases such as yellow fever and polio where proof of vaccination is often needed. Vaccine requirements change over time, too. In the case of malaria, for example, the affected areas can shift. And then there's the fact that vaccinations aren't always straightforward. Depending on the vaccine, you might be fine with just one dose or you might need multiple doses over months. Here's what you need to know.
This article contains affiliate links, which may earn us revenue
Before any travel abroad, check your routine immunisations are up to date, because many are common travel vaccines — such as tetanus, diphtheria, poliomyelitis, MMR (measles, mumps and rubella) and hepatitis B. Childhood vaccinations received will differ between age groups, as well as other factors, and some require boosters over time. For example, diphtheria has a recommended ten-yearly booster if travelling in high-risk areas.
Hepatitis B hasn't always been a routine immunisation, so you may want to ask your GP about your status. Infections like hepatitis B are spread through bodily fluids, so sensible precautions should be taken with sexual encounters, medical procedures, tattoos and piercings.
While not usually part of the routine schedule, hepatitis A and typhoid are such common recommendations worldwide that they're often worth getting for travel. All the above, plus cholera, are usually free on the NHS, but hepatitis B is only available to certain groups (you can expect to pay about £150 privately for a three-dose course).
Covid-19 and seasonal flu jabs are also recommended, especially for those normally considered in an at-risk group — or, in some instances, travelling to crowded places such as festivals and religious or sporting events.
Many common travel illnesses don't have vaccines, like the all-too-familiar travellers' diarrhoea, which most commonly presents after consuming contaminated food or water. Altitude sickness should be taken into account when visiting any destination above 2,400m.
Vaccination isn't suitable or possible for a number of mosquito-borne diseases — however, there can be exceptions, for example if you've had a previous infection of dengue.
Always research possible health risks and take appropriate precautions, including all-important travel insurance. Make sure any medications you take can be legally brought into your destination — some restrictions may surprise you.
Most European pathogens are covered by UK routine vaccinations. Hepatitis A jabs are often recommended — it's spread through faeces, so thrives around poor sanitation and contaminated water.
Several European countries pose a risk of rabies and the vaccine is usually given in three doses over four weeks, although this can be shortened where time is an issue. It costs about £200 for the course — but even then, the vaccine won't fully protect you. If you've been bitten, scratched or, in some cases, licked by an infected animal (bear in mind, its symptoms might not be present), seek immediate medical attention to prevent the fatal disease.
Tick-borne encephalitis is present in northern, central and eastern Europe. Consider getting the vaccine for outdoor pursuits such as hiking, camping, cycling or fishing, in at-risk countries. Three doses over 12 months — about £200 — offers full protection, but there's also an accelerated course, and boosters are encouraged.
France, Spain and Italy have in recent years reported cases of dengue. This nasty mosquito-borne infection can be fatal and there's no vaccine (except in instances of previous infection). Cover up from dawn until dusk, and use insect repellents.
• Cyprus travel advice: is it safe to visit right now?• Is it safe to travel to Turkey right now? Latest travel advice
Vaccine recommendations vary greatly over huge continents like Asia. Beyond routine immunisations, typhoid and hepatitis A are the most common and both are free on the NHS. Typhoid is spread mainly through contaminated food and drink.
Depending on trip duration and previous travel, some countries demand international certification of a recent polio booster; check requirements for Pakistan, India and Indonesia in particular. Though Asia doesn't have yellow fever, countries like India or Singapore may need to see vaccine proof if you're travelling from affected countries.
A rabies vaccination is suggested for most destinations, including India, Indonesia, Thailand and China. Rabies risk is far higher in countries with lots of wild or stray animals — steer clear, however cute. The three-dose vaccine is expensive (about £200) but can save lives.
Shots for tick-borne encephalitis (about £200) are suggested if undertaking outdoor activities in affected destinations. Certain at-risk travellers are advised to get vaccinated for Japanese encephalitis (about £200 for a two-dose course) and cholera (free on the NHS) — depending on factors such as personal health, type of activities and duration of stay.
In some regions, mosquitoes carry malaria, dengue and zika (which can cause birth defects). While there is little in the way of vaccines here, for malaria you can take antimalarial tablets; there's a wide variety available, with differing doses, prices and side effects. Most require a prescription, although they can be requested easily from pharmacies online without seeing your GP. This is the safer, preferred option when buying antimalarial tablets online, which could either be fakes or not the correct type you need for your travels.
In general, insect and water precautions are advised across most Asian destinations.
Pilgrims heading to haj or umra will need, among other requirements, proof of a meningococcal meningitis vaccine (about £60) given within the past three years, and no less than ten days before arrival.
• Dubai travel advice: is it safe to visit right now?• Is it safe to travel to Sri Lanka? Everything you need to know
Africa is a massive continent with myriad vaccine recommendations — routine immunisations, hepatitis A and typhoid are a given. If staying longer than four weeks in many countries, a polio booster with international certification is advised.
Africa has many wild and stray animals, so consider the three rabies doses for afflicted countries (about £200). Dogs, cats, bats and monkeys are prime candidates for carrying the disease. Many of the UK's favourite African destinations — Egypt, Morocco, South Africa, Tunisia, Mauritius — don't suggest vaccines beyond these.
Yellow fever sets Africa apart. Present in popular destinations such as Kenya and Uganda, the virus is transmitted by mosquitoes and can turn deadly. Many countries will insist you carry your original vaccination certificate when travelling to, from or through affected countries (jabs cost about £70). Mosquitoes may also carry malaria, dengue and zika. Antimalarial tablets are advised in high-risk areas.
Some African destinations, such as Nigeria, Uganda and Kenya, experience meningococcal meningitis epidemics. Jabs cost about £60. Spread person to person through droplets, some meningitis forms are covered under routine immunisations, but boosters are often advised. Cholera vaccination may be recommended to certain at-risk travellers.
Sub-Saharan Africa accounts for about 90 per cent of the world's schistosomiasis cases. It's caught when a parasite living in fresh water comes into contact with your skin, for example when swimming and bathing. So always be cautious with water and hygiene.
• Morocco travel advice: is it safe to visit right now?• How to see gorillas in Rwanda: everything you need to know
Routine immunisations, hepatitis A and typhoid are advised for South America. Like Africa, much of South America has yellow fever — so vaccination is a good idea (about £70). Be sure to carry proof with you, where needed, for entry and exit requirements. Mosquitoes may also spread malaria, zika and dengue, so cover up, wear repellent, and take antimalarial tablets in affected areas.
Prolific wildlife and stray animals mean rabies vaccination is recommended for many South American countries (about £200). Even with three doses, you'll need urgent medical attention should risk of infection occur.
Great swathes of South America are high altitude (above 2,400m), so beware of altitude sickness.
• The otherworldly desert that's brilliant for stargazing• How to find the real 'Old World' Buenos Aires
UK travellers to Canada and the US need only consider routine vaccinations, hepatitis A and altitude sickness. Rabies is rare, but you may want to consider the three-dose vaccine (about £200).
Routine vaccines, hepatitis A and typhoid are recommended for Caribbean and Central American destinations. Dengue and zika are prevalent across both regions, so protect against mosquito bites. Malaria is often low to no risk, but is present in some countries — for example, Honduras, where antimalarial tablets are advised for high-risk areas.
The NHS recommends travellers consider the rabies vaccine for some Central American and Caribbean destinations, such as Panama and Cuba; and cholera for those who might be at-risk on Hispaniola.
Panama and Trinidad & Tobago have yellow fever, so get a vaccine plus a certificate if travelling on to countries that demand them (about £70).
Some Central American destinations have areas of high altitude.
• Cuba travel guide• I've found the most beautiful train ride in America
Australia and New Zealand are recommended the usual vaccines, and hepatitis A for at-risk travellers. Australia also suggests Japanese encephalitis shots for at-risk visitors (about £200), which is usually spread by mosquitoes in rural areas. Some Australian regions have dengue fever, so take the necessary precautions.
Many Pacific Island destinations add hepatitis A and typhoid to recommended routine vaccines. Only Kiribati has rabies, and you should consider the vaccine. Mosquito-borne dengue is found across many islands, while destinations such as Fiji, Samoa and Tonga have zika. Take insect precautions to lower your risk of infection.
Vanuatu, Papua New Guinea and the Solomon Islands have malaria, so antimalarial medications are advised. The latter two also have zika. It's recommended at-risk travellers get cholera and Japanese encephalitis vaccines for Papua New Guinea too.
• Australia travel guide• New Zealand travel guide

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money
The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money

The Sun

time22 minutes ago

  • The Sun

The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss injections, which can cost hundreds of pounds a month, are designed to deliver a fixed weekly dose. But online users claim there's still a small amount of drug left after the final shot. They say it can be drawn out with a syringe for a bonus jab, dubbed the 'golden dose'. One TikTok user claimed the trick saved her a fortune. By getting five jabs from a four-dose pen, users reckon they can claw back £615 a year. The reports come after NHS England said only a small number of people will be able to get Mounjaro from their GP. It means most people will still have to pay for it privately - which can cost hundreds of pounds a month. 'The drugs are expensive but weight loss is strongly desired, so as a commodity, these drugs are hotly sought-after,' said Professor Naveed Sattar, a cardiologist and obesity expert at the University of Glasgow, said. 'It's no surprise people are going to such extraordinary lengths," she told the inews. Medics say the DIY hack is dangerous and could lead to infection, overdose or death. "People are reading these tips on online forums and being tempted to use them to save money," said Professor Penny Ward, a pharmaceutical expert at King's College London. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies "But they're risking serious side effects from overdosing by doing this - as well as the potential to develop a life-threatening infection. "The potential to develop a life-threatening infection. It's not a good idea at all," she told MailOnline. Talk of the so-called 'golden dose' is also spreading on Reddit weight-loss forums. In one thread with more than 50 comments, a user wrote: "After four pumps of your uk injection pen they tell you to throw it away. "But there is an extra dose or thereabouts in the pen you can self inject with an insulin needle." Another replied saying: "Known much more on here as the fifth dose." 2 Slimmers have also taken to TikTok to rave about the 'discovery'. In one video, a nurse demonstrates how to use a needle to extract leftover medicine from the pen. She wrote: "I do not condone or encourage anybody to take their golden dose this is just what I am doing." Huge risks Professor Penny warned that this practice can be dangerous for "several" reasons. "These injections contain a slight overfill to ensure the full recommended dose is delivered each time," she said. "But by drawing this out with a separate syringe and using it as a so-called fifth dose, you're exposing yourself to serious risk of infection.' Once the pen has been used, it's no longer sterile, meaning any leftover liquid could be contaminated with harmful bacteria. Injecting it could lead to abscesses or, in extreme cases, life-threatening sepsis. There's also the danger of taking too much. 'If you're using your own syringe, it's difficult to measure the correct amount - you may end up taking more than intended,' she warned. Overdosing on the jab can trigger nasty side effects like vomiting and diarrhoea, or in rare cases, pancreatitis - a serious and painful condition that may need hospital treatment. Around one in five cases result in serious complications, with up to 30 per cent proving fatal. The risk rises sharply with higher doses, as the drug can trigger digestive enzymes that begin attacking the pancreas itself. Symptoms include sudden, severe tummy pain, often spreading to the back, along with fever, nausea and a racing heartbeat. "The bigger the dose, the bigger the risk of pancreatitis," Professor Ward warned. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Mounjaro - dubbed the "King Kong" of weight loss jabs - works by mimicking hormones released by the body when you're full. This makes people feel fuller for longer and therefore less hungry. It appears to be to be more potent than Wegovy - another popular weight loss jab - causing about 20 per cent weight loss after a year's use, compared with Wegovy's 15 per cent. Mounjaro's active ingredient is tirzepatide, a lab-made compound that mimics two gut hormones - GLP-1 and GIP - which help control blood sugar and appetite. This is why it was initially approved to treat diabetes type 2, which happens when people can't control their blood sugar. But in December 2024, it was also cleared for use on the NHS for weight loss in people with a BMI of over 30, or over 27 plus one weight-related condition. 'Excess solution' should be 'discarded' If you notice there is a considerable amount of medication left in your pen after the last dose, Professor Penny added, it may mean that you're not using the injection properly. "Speak to your pharmacist about your technique, or check that you definitely have the right size syringe, as this can impact the amount of medication left over," she said. A spokesperson for Lilly - the drug's manufacturer - said users should not do this, as the remaining liquid may not be a full dose. 'It is important to note that there will be a residual amount of medicine left after the fourth dose," they said. "This does not correspond to a full dose." 'Any excess solution in the pen after use should be discarded.' Dr Alison Cave, chief safety officer of the Medicines and Healthcare products Regulatory Agency, added: "Medicines are approved according to strict dosage guidelines. "Failure to adhere with these guidelines, such as tampering with pre-dosed injection pens, could harm your health or cause personal injury. "People should follow the dosing directions provided by their healthcare provider when prescribed weight-loss medicines and use as directed in the patient information leaflet." What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.

Labour pledges to lower A&E waiting times and end NHS ‘corridor care'
Labour pledges to lower A&E waiting times and end NHS ‘corridor care'

The Independent

time28 minutes ago

  • The Independent

Labour pledges to lower A&E waiting times and end NHS ‘corridor care'

The government has pledged to drastically reduce the number of patients facing long waits in A&E, with plans also set out to end "corridor care". According to the Department of Health and NHS England, almost £450 million will be invested in creating better care and more facilities, with an emphasis on caring for people closer to their homes. The new Urgent and Emergency Care Plan for England states that more needs to be done to drive down long waits, cut delayed discharges, and improve care for patients. An earlier version of the document said NHS trusts would need to show how, by this winter, systems will "improve flow through hospitals, with a particular focus on patients waiting over 12 hours, and eliminate corridor care". The later version does not commit to a timescale for ending corridor care, instead stating that systems must "improve flow through hospitals, with a particular focus on reducing patients waiting over 12 hours and making progress on eliminating corridor care". Ministers have also set an ambition for a minimum of 78% of patients who attend A&E to be admitted, transferred, or discharged within four hours, up from the current 75%, meaning "over 800,000 people a month will receive more timely care". There will also be a focus on seeing more children. The Government wants to slash the number of patients waiting more than 12 hours for a hospital bed – or to be discharged from A&E – so this occurs 'less than 10% of the time', according to the new document. Around 1.7 million attendances at A&E every year currently exceed this time frame. Further measures in the plan are intended to drive down delayed discharges from hospital, which occur when people are medically fit to leave but care in their homes or community has not yet been put in place. Local performance targets will be set to improve patient discharge times, and 'eliminate internal discharge delays of more than 48 hours in all settings', the plan said. Experts said A&E 'league tables' will be published to drive up performance. Those patients who need an overnight emergency admission will also have their overall stay reduced where appropriate – the average is 'currently nearly a day longer than in 2019'. The plan further sets out how ambulance waiting times for category 2 patients – such as those suffering stroke, heart attack, sepsis or major trauma – will be cut by more than 14%, from 35 to 30 minutes. A previous target of 18 minutes has been repeatedly missed. In the document, there is an aim to 'eradicate' last winter's lengthy ambulance handover delays by meeting a maximum 45-minute target for patients to be handed over to A&E. This should help 'get 550,000 more ambulances back on the road for patients', it says. According to the document, around 40 new same day emergency care and urgent treatment centres will also be established to treat and discharge patients the same day, avoiding unnecessary admissions to hospital. Almost 500 new ambulances will also be rolled out across the country by March 2026. The plan details 15 mental health crisis assessment centres, which are designed to ensure mentally ill people do not have to wait in A&E for hours for care. It comes after the NHS experienced a crisis over winter, with patients waiting hours for beds and regularly being treated in corridors – so-called corridor care. A&E waiting time targets have not been met for more than a decade, while the 18-minute target for category 2 ambulance calls has never been hit outside the pandemic. Health Secretary Wes Streeting said: 'No patient should ever be left waiting for hours in hospital corridors or for an ambulance which ought to arrive in minutes. 'We can't fix more than a decade of underinvestment and neglect overnight. 'But through the measures we're setting out today, we will deliver faster and more convenient care for patients in emergencies. 'Far too many patients are ending up in A&E who don't need or want to be there, because there isn't anywhere else available. 'Because patients can't get a GP appointment, which costs the NHS £40, they end up in A&E, which costs around £400 – worse for patients and more expensive for the taxpayer. 'The package of investment and reforms we are announcing today will help the NHS treat more patients in the community, so they don't end up stuck on trolleys in A&E.' Under the plans, paramedics will play a bigger role in the community, with patients given 'more effective treatment at the scene of an accident or in their own homes from ambulance crews'. More patients will also be seen by urgent community response teams in their own homes to try to avoid hospital admission. The NHS is also pledging better use of virtual wards, where patients are monitored by hospital staff from their home, and there are plans to drive up vaccination rates among NHS staff to help protect patients. The Liberal Democrats claimed the Government had listened to their calls to end corridor care, but called on ministers to follow through on their promises. Lib Dem health spokesperson Helen Morgan MP said: 'Patients have heard these kinds of promises before only to be led up the garden path. 'We can't bear any more of the shameful neglect and failed delivery that we saw for a decade under the Conservatives. 'It's good to see ministers finally listen to Liberal Democrat demands to end corridor care but the misery in our A&Es will only be prolonged if they continue to move at a snail's pace on social care. 'Until they grasp this nettle, millions are at risk of dangerously long waits in A&E. 'They must see sense and conclude their review into social care by the end of this year.'

Brighton GP practice investigated for prescribing trans hormones to children
Brighton GP practice investigated for prescribing trans hormones to children

Telegraph

timean hour ago

  • Telegraph

Brighton GP practice investigated for prescribing trans hormones to children

An investigation into a GP clinic in Brighton that prescribed transgender hormones to children has been launched by the NHS. The WellBN GP practice, which runs three clinics in Sussex, was ordered by health service leaders to stop prescribing cross-sex hormones to under 18s and the NHS has now launched a 'rapid investigation'. The NHS Sussex Integrated Care Board, which oversees the region's health services, said that the actions of GPs at WellBN 'may fall outside of national clinical policy and guidance'. 'Following concerns raised about some prescribing for children and young people by WellBN in Brighton and Hove, that may fall outside of national clinical policy and guidance, we are working with NHS England and have launched a rapid investigation into this activity to determine the most appropriate care and treatment for these patients,' it said. The administration of cross-sex drugs, also known as gender-affirming hormones, involves giving hormones such as testosterone to help someone change their physical appearance. They are different to puberty blockers, which stop the onset of puberty by suppressing the release of hormones. The Cass review, led by the paediatrician Baroness Hilary Cass, said all under 18s questioning their gender should be seen by a team of experts for a range of conditions, including mental health issues and neurodevelopmental disorders such as autism, before any treatment is considered. 'Extreme caution' recommended The independent review concluded that medical pathways to change genders had been 'built on shaky foundations' and called for puberty blockers to be banned, citing the 'weak evidence' to support their use in this group of patients. It urged 'extreme caution' in relation to cross-sex hormones in under 18s. But WellBN continued to prescribe the drugs, claiming on its website that it would prescribe the hormones to patients with a referral to a gender identity clinic while they waited for an appointment, and that it would also arrange a referral for any patients who did not have one. The GP practice is already the subject of a legal challenge by the parents of Child O, an anonymous 16-year-old boy, who claimed their child was prescribed cross-sex hormones without having been properly assessed by a gender-identity clinic and without their knowledge. The clinic previously said it had 'fully considered and responded back to the correspondence received from the family's representatives and will engage fully on any next steps'. It also said it is 'confident that any young patients under the age of 18 are assessed in accordance with good medical practice', adding: 'Gillick competence and bodily autonomy are at the heart of all care we offer and this framework is consistently applied.' 'Trans health hub' The practice operates a 'trans health hub' and patients - of which it says around 2,000 are trans or non-binary - can receive annual check-ups with 'a supportive and affirming clinician'. It has defended its prescribing of hormones to under 18s based on an 'informed consent pathway', which it says 'sets out the risks, potential side effects and reversible and irreversible intended effects of hormone therapy'. It comes after Wes Streeting last month ordered a review into the use of cross-sex hormones in children, which could join puberty blockers in being banned for use in under 18s to treat gender dysphoria. NHS Sussex said the majority, but not all, of the children being prescribed cross-sex hormones by the clinic lived in the region and that it would be reviewing each case to consider next steps for their treatment and care. 'The cohort of patients whose cases are being reviewed are all aged under 18, and for whom WellBN is prescribing or arranging the supply of medication for gender dysphoria,' it said. 'There will be a process to review their notes, and consider next steps in their treatment, in line with national guidance and clinical advice.' Temporary pause It said there would be 'different outcomes for different patients', with some referred to specialist NHS gender services, others seen by local mental health services, while some would have their hormone treatment reviewed. WellBN revealed last week that the NHS had 'forced us to temporarily pause initiating new NHS prescriptions for gender-affirming care to anyone under the age of 18', including a ban on taking on prescriptions from private sector providers. It vowed to try to 'turn this decision around' and said it would be meeting with NHS Sussex. Rachel Cashman, co-founder of community group PSHE Brighton, said she welcomed the investigation, adding that parents she had spoken with had been 'concerned' about WellBN's approach to treating under 18s with gender issues for some time. ' Gender distressed children deserve the most clinically efficacious treatment,' she said. 'PSHE Brighton welcomes an investigation by NHS England into the care provided by this service'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store